A detailed history of Algert Global LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Algert Global LLC holds 73,627 shares of AXNX stock, worth $5.23 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
73,627
Previous 33,847 117.53%
Holding current value
$5.23 Million
Previous $2.28 Million 125.13%
% of portfolio
0.14%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$67.3 - $69.67 $2.68 Million - $2.77 Million
39,780 Added 117.53%
73,627 $5.12 Million
Q2 2024

Aug 14, 2024

BUY
$66.47 - $69.65 $463,827 - $486,017
6,978 Added 25.97%
33,847 $2.28 Million
Q1 2024

May 14, 2024

SELL
$56.67 - $69.36 $285,050 - $348,880
-5,030 Reduced 15.77%
26,869 $1.85 Million
Q4 2023

Feb 14, 2024

BUY
$49.38 - $63.75 $419,680 - $541,811
8,499 Added 36.32%
31,899 $1.99 Million
Q3 2023

Nov 13, 2023

BUY
$48.64 - $62.51 $1.14 Million - $1.46 Million
23,400 New
23,400 $1.31 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.